Cytotoxic Drugs Contract Manufacturing Market
- 2026 年市場規模
- USD 12,606.5 Mn
- 2033 年預估規模
- USD 23,157.5 Mn
- 年複合成長率 CAGR
- 9.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cytotoxic Drugs Contract Manufacturing Market, By Production Scale (Industrial Scale, Pilot Scale, and Laboratory Scale), By Form (Liquid, and Solid), By Product Type (Oral and Intravenous), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.
Market Dynamics
Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.
Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology’s COPIKTRA (duvelisib) capsules.
Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences’ proprietary active pharmaceutical ingredients (APIs) for its Parkinson’s disease therapies.
Key features of the study
• This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
• The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market
Market Segmentation
• Production Scale Insights (Revenue, USD Mn, 2026 - 2033)
o Industrial scale
o Pilot Scale
o Laboratory Scale
• Form Insights (Revenue, USD Mn, 2026 - 2033)
o Liquid
o Solid
• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
o Oral
o Intravenous
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Lonza Group
o Piramal Group
o Evonik Industries AG
o Novasep Holding SAS
o Merck KGaA (SAFC Pharma)
o Baxter Biopharma Solutions
o AbbVie Contract Manufacturing
o Cambrex Corporation
o BSP Pharmaceuticals S.p.A.
o CordenPharma Internatisonal
o Catalent, Inc.
o Albany Molecular Research Inc.
o Evotec
o WuXi AppTec Co., Ltd.
o Pierre Fabre Laboratories
o Dishman Group
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Production Scale
Market Snippet, By Form
Market Snippet, By Product Type
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Epidemiology
o Market Trends
o Product Launch
o Regulatory Scenario
o PEST Analysis
o Merger and Acquisition Scenario
o Technological Advancements
4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Industrial scale
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Pilot Scale
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Laboratory Scale
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Liquid
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Solid
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Oral
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Intravenous
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Production Scale, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Form, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Lonza Group
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Piramal Group
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Evonik Industries AG
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novasep Holding SAS
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck KGaA (SAFC Pharma)
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Baxter Biopharma Solutions
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AbbVie Contract Manufacturing
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cambrex Corporation
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
CordenPharma International
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
BSP Pharmaceuticals S.p.A.
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Catalent, Inc.
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Albany Molecular Research Inc. (AMRI)
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Evotec
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
WuXi AppTec Co., Ltd.
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pierre Fabre Laboratories
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Dishman Group
o Company Overview
o Form Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們